Exercise and nutrition effect on Autism

Effect of Functional Exercise Along with online Nutritional Education on Inflammatory-Oxidative and Metabolic Profile in Children with Autism Spectrum Disorder during Covid-19 Pandemic

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20201211049678N1

Enrollment

Registered

2021-07-29

Start date

2021-07-11

Completion date

Unknown

Last updated

2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorder.

Interventions

Intervention 1: Functional group, will participate in 8 weeks functional training including warm up, going up and down the stairs, sit-to-stand using weight and cool down at the end of the sessions fo

Eligibility

Sex/Gender

Male

Age

8 Years to 12 Years

Inclusion criteria

Inclusion criteria: Autism spectrum disorder diagnosis approved by neurologist No inhibition for physical activity No experience of physical activity within past 6 month Not reaching maturity according to specialist diagnosis

Exclusion criteria

Exclusion criteria: Reaching to puberty according to specialist approval Any prohibition from physical activity Any medical conditions or disease which inhibits physical activity

Design outcomes

Primary

Measure	Time frame
Lower limb strength. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Sits to stand test.;Upper limb strength. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: 1 kilogram dumbbell press.;Abdominal strength. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Push ups test.;Flexibility. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Modified sit and reach test.;Cardio-respiratory endurance. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: 6 minutes walking test.;Lipid profile. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Anterior cubital vein blood sample.;Insulin resistance indicator. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Anterior cubital vein blood sample.;Waist to hip circumference ratio (WHR). Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Waist and hip circumference measurement and division to each other.;Fat mass. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Caliper.;C-reactive protein (CRP). Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Anterior cubital vein blood sample.;White blood cells (WBC). Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Anterior cubital vein blood sample.;Superoxide dismutase enzyme (SOD). Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of	—

Measure

Time frame

Lower limb strength. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Sits to stand test.;Upper limb strength. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: 1 kilogram dumbbell press.;Abdominal strength. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Push ups test.;Flexibility. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Modified sit and reach test.;Cardio-respiratory endurance. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: 6 minutes walking test.;Lipid profile. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Anterior cubital vein blood sample.;Insulin resistance indicator. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Anterior cubital vein blood sample.;Waist to hip circumference ratio (WHR). Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Waist and hip circumference measurement and division to each other.;Fat mass. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Caliper.;C-reactive protein (CRP). Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Anterior cubital vein blood sample.;White blood cells (WBC). Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Anterior cubital vein blood sample.;Superoxide dismutase enzyme (SOD). Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of

—

Secondary

Measure	Time frame
Lower limb muscle strenght. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Sit-to-stand test.;Upper limb muscle strenght. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: 1 kilogram dumbbell press.;Abdominal muscle strenght. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Push-ups test.;Flexibility. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Modified sit-and-reach test.;Cardio-respiratory endurance. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: 6 minutes walking test.;Lipid profile indicators. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Anterior cubital vein blood sample.;Insulin resistance indicator. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Anterior cubital vein blood sample.;Waist-to-hip ratio. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Waist and hip circumference measurement and division to each other.;Fat mass. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Caliper.;C-reactive protein. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Anterior cubital vein blood sample.;White blood cells. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Anterior cubital vein blood sample.;Superoxide dismutase enzyme. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measur	—

Measure

Time frame

Lower limb muscle strenght. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Sit-to-stand test.;Upper limb muscle strenght. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: 1 kilogram dumbbell press.;Abdominal muscle strenght. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Push-ups test.;Flexibility. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Modified sit-and-reach test.;Cardio-respiratory endurance. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: 6 minutes walking test.;Lipid profile indicators. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Anterior cubital vein blood sample.;Insulin resistance indicator. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Anterior cubital vein blood sample.;Waist-to-hip ratio. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Waist and hip circumference measurement and division to each other.;Fat mass. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Caliper.;C-reactive protein. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Anterior cubital vein blood sample.;White blood cells. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Anterior cubital vein blood sample.;Superoxide dismutase enzyme. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measur

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMandana Gholami

Islamic Azad University

gholami_man@yahoo.com+98 21 4486 5179

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026